[{"address1": "Room 325, 55 Claverick Street", "city": "Providence", "state": "RI", "zip": "02903", "country": "United States", "phone": "401 444 7375", "website": "https://www.oceanbiomedical.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Inderjote  Kathuria M.B.A., M.D.", "age": 56, "title": "Chief Strategy Officer", "yearBorn": 1967, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chirinjeev Baboo Kathuria M.B.A., M.D.", "age": 58, "title": "Founder & Executive Chairman of the Board", "yearBorn": 1965, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. M. Michelle Berrey M.D., M.P.H.", "age": 56, "title": "Interim CEO & Director", "yearBorn": 1967, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack A. Elias M.D.", "age": 72, "title": "Founder, Chairman of Scientific Advisory Board & Independent Director", "yearBorn": 1951, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jonathan  Kurtis M.D., Ph.D.", "age": 55, "title": "Founder, Chairman of Scientific Advisory Board & Director", "yearBorn": 1968, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jolie G. Kahn CPA, Esq.", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1965, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert John Sweeney", "age": 58, "title": "Chief Accounting Officer & Assistant Secretary", "yearBorn": 1965, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.673, "open": 0.69, "dayLow": 0.673, "dayHigh": 0.7, "regularMarketPreviousClose": 0.673, "regularMarketOpen": 0.69, "regularMarketDayLow": 0.673, "regularMarketDayHigh": 0.7, "beta": 1.529, "forwardPE": -0.78, "volume": 51038, "regularMarketVolume": 51038, "averageVolume": 49958, "averageVolume10days": 43270, "averageDailyVolume10Day": 43270, "bid": 0.6642, "ask": 0.7319, "bidSize": 100, "askSize": 100, "marketCap": 24171072, "fiftyTwoWeekLow": 0.52, "fiftyTwoWeekHigh": 7.79, "fiftyDayAverage": 0.85168, "twoHundredDayAverage": 1.549005, "currency": "USD", "enterpriseValue": 41385332, "floatShares": 7517457, "sharesOutstanding": 34818600, "sharesShort": 165459, "sharesShortPriorMonth": 183682, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0047999998, "heldPercentInsiders": 0.71989, "heldPercentInstitutions": 0.10543, "shortRatio": 2.64, "shortPercentOfFloat": 0.0162, "impliedSharesOutstanding": 34818600, "bookValue": -2.207, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -98593000, "trailingEps": -4.35, "forwardEps": -0.89, "52WeekChange": 0.12166667, "SandP52WeekChange": 0.31426477, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "OCEA", "underlyingSymbol": "OCEA", "shortName": "Ocean Biomedical, Inc.", "longName": "Ocean Biomedical, Inc.", "firstTradeDateEpochUtc": 1636381800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "3912ca55-c0cf-3bf3-81ae-9047b9a5b9b3", "messageBoardId": "finmb_669640055", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.6942, "recommendationKey": "none", "totalCash": 31000, "totalCashPerShare": 0.001, "totalDebt": 17162000, "quickRatio": 0.001, "currentRatio": 0.033, "returnOnAssets": -6.8198605, "freeCashflow": 1556091, "operatingCashflow": -8596000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-07"}]